Epurines

04/27/2024

https://www.youtube.com/watch?v=es83gMD9vws&list=PLcd0BHRIDcDm-LCfWVCz6uiXo23twS32q&index=5

Diet-induced obesity is a global problem leading to metabolic syndrome, diabetes mellitus, and other non-communicable diseases (NCDs). Two-thirds of the affe...

11/11/2023

08/20/2022

https://techlinkcenter.org/news/va-salt-lake-city-research-on-kidney-disease-treatment-earns-second-us-patent

Ticagrelor used to decrease arginine vasopressin production, prevent cyst formation

08/25/2021

Salt Lake City Utah based ePurines is raising $5,000,000.00 in New Equity Investment.

Salt Lake City, UT - According to filings with the U.S. Securities and Exchange Commission, ePurines is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Bellamkonda

08/25/2021

https://eilifesciencessummit.org/company/epurines-inc/

ePurines, Inc is a drug development startup focused on innovative purinergic signaling- based therapies for obesity, metabolic syndrome, and kidney and liver diseases.

08/25/2021

Salt Lake City–After securing an option in May 2020, BioMed startup ePurines finalized an exclusive patent license agreement with the U.S. Department of Veterans Affairs on May 28.

Salt Lake City–After securing an option in May 2020, BioMed startup ePurines finalized an exclusive patent license agreement with the U.S. Department of Veterans Affairs on May 28. The agreement allows ePurines to commercialize a freshly patented purinergic signaling technology developed by Dr. BK...

08/25/2021

Welcome to ePurines, Inc., the start up drug development company in the University of Utah Research Park, Salt Lake City, Utah, United States.

ePurines was founded by internationally recognized experts in purinergic signaling, and exclusively focuses on the development of purinergic signaling-based therapeutics. ePurines is developing innovative therapies targeting purinergic signaling in obesity, metabolic syndrome, and renal and liver diseases.

ePurines’ genesis is linked to improving the Veterans health. The core technologies were developed and patented by the US Department of Veterans Affairs, and were licensed to ePurines.